诱导化疗-话题@MedSci

#诱导化疗#

24篇内容 | 971人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2183332, encodeId=e3592183332af, content=<a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治疗#</a> <a href='/topic/show?id=146246308d1' target=_blank style='color:#2F92EE;'>#宫颈癌#</a> <a href='/topic/show?id=e65f93688dc' target=_blank style='color:#2F92EE;'>#辅助治疗#</a> <a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=盘点2023｜曹新平教授：2023年宫颈癌领域进展, objectType=article, longId=810485, objectId=fb68810485cb, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-leading-a-medical-team-at-hospital-DQZSHGT.jpg, objectUrl=/article/show_article.do?id=fb68810485cb, replyNumber=0, likeNumber=31, createdTime=2024-01-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=fb68810485cb, moduleTitle=盘点2023｜曹新平教授：2023年宫颈癌领域进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb68810485cb)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1555673, encodeId=144415556e3ef, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=Blood Cancer J：小儿急性髓性白血病的两药与三药诱导化疗比较：一项随机对照试验, objectType=article, longId=738707, objectId=ecc7e3870745, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecc7e3870745, replyNumber=0, likeNumber=36, createdTime=2022-09-10, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecc7e3870745, moduleTitle=Blood Cancer J：小儿急性髓性白血病的两药与三药诱导化疗比较：一项随机对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecc7e3870745)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555672, encodeId=17e015556e216, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=Lancet Haematol：维奈托克联合诱导化疗治疗新诊断的急性髓性白血病患者, objectType=article, longId=728602, objectId=6aa5e2860281, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6aa5e2860281, replyNumber=0, likeNumber=42, createdTime=2022-06-05, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6aa5e2860281, moduleTitle=Lancet Haematol：维奈托克联合诱导化疗治疗新诊断的急性髓性白血病患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6aa5e2860281)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555671, encodeId=02ce15556e13d, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=Lancet Haematol：维奈托克联合强化诱导化疗治疗新发急性髓系白血病, objectType=article, longId=727923, objectId=0964e27923ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0964e27923ac, replyNumber=0, likeNumber=30, createdTime=2022-05-28, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0964e27923ac, moduleTitle=Lancet Haematol：维奈托克联合强化诱导化疗治疗新发急性髓系白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0964e27923ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555670, encodeId=370c15556e053, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=JAMA Oncol：紫杉醇+顺铂+卡培他滨诱导化疗可改善晚期鼻咽癌患者的生存预后, objectType=article, longId=302272, objectId=31553022e20d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31553022e20d, replyNumber=0, likeNumber=41, createdTime=2022-04-04, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31553022e20d, moduleTitle=JAMA Oncol：紫杉醇+顺铂+卡培他滨诱导化疗可改善晚期鼻咽癌患者的生存预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31553022e20d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555669, encodeId=862e15556691f, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=Front Oncol：比较同步放化疗联合诱导化疗或辅助化疗在II–IVA期鼻咽癌患者中的疗效和安全性, objectType=article, longId=221519, objectId=836f22151965, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=836f22151965, replyNumber=0, likeNumber=34, createdTime=2021-12-05, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=836f22151965, moduleTitle=Front Oncol：比较同步放化疗联合诱导化疗或辅助化疗在II–IVA期鼻咽癌患者中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=836f22151965)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555668, encodeId=c7301555668cb, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=Front Oncol：诱导化疗联合调强放疗(IMRT)治疗同时性转移鼻咽癌患者的疗效, objectType=article, longId=218758, objectId=6628218e582f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6628218e582f, replyNumber=0, likeNumber=38, createdTime=2021-10-19, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6628218e582f, moduleTitle=Front Oncol：诱导化疗联合调强放疗(IMRT)治疗同时性转移鼻咽癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6628218e582f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555667, encodeId=bc28155566e1a, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=Front Oncol：局部晚期鼻咽癌三种诱导化疗的疗效和毒性：10年随访结果, objectType=article, longId=218614, objectId=3d32218614c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d32218614c3, replyNumber=0, likeNumber=56, createdTime=2021-10-16, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d32218614c3, moduleTitle=Front Oncol：局部晚期鼻咽癌三种诱导化疗的疗效和毒性：10年随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d32218614c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555666, encodeId=8916155566605, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=Nat Commun：食管鳞状细胞癌中诱导化疗结合根治性放化疗与单独放化疗的疗效比较, objectType=article, longId=213631, objectId=4164213631f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4164213631f5, replyNumber=0, likeNumber=0, createdTime=2021-07-03, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4164213631f5, moduleTitle=Nat Commun：食管鳞状细胞癌中诱导化疗结合根治性放化疗与单独放化疗的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4164213631f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555665, encodeId=02931555665c6, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=J Clin Oncol：Romyelocel-L可显著降低AML患者诱导化疗期间的感染风险, objectType=article, longId=213191, objectId=526521319116, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=526521319116, replyNumber=0, likeNumber=31, createdTime=2021-06-26, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=526521319116, moduleTitle=J Clin Oncol：Romyelocel-L可显著降低AML患者诱导化疗期间的感染风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=526521319116)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555664, encodeId=4ed6155566478, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=Blood：多发性骨髓瘤老年患者Rd诱导化疗后可单采用低剂量来那度胺维持治疗, objectType=article, longId=212562, objectId=61ab21256220, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61ab21256220, replyNumber=0, likeNumber=42, createdTime=2021-06-12, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61ab21256220, moduleTitle=Blood：多发性骨髓瘤老年患者Rd诱导化疗后可单采用低剂量来那度胺维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61ab21256220)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555663, encodeId=5f2a15556631b, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=Blood：极低风险的ALL患儿采用低强度诱导化疗即可获得很好的预后！, objectType=article, longId=205775, objectId=6e66205e750c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e66205e750c, replyNumber=0, likeNumber=57, createdTime=2021-01-17, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e66205e750c, moduleTitle=Blood：极低风险的ALL患儿采用低强度诱导化疗即可获得很好的预后！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e66205e750c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555662, encodeId=b1ba15556622b, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=Plos Med：卡非佐米+来那度胺+地塞米松和环磷酰胺用作多发性骨髓瘤移植前诱导化疗的效果和安全性, objectType=article, longId=205699, objectId=a34920569953, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a34920569953, replyNumber=0, likeNumber=39, createdTime=2021-01-15, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a34920569953, moduleTitle=Plos Med：卡非佐米+来那度胺+地塞米松和环磷酰胺用作多发性骨髓瘤移植前诱导化疗的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a34920569953)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555661, encodeId=6ec9155566128, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=Lancet Gastroenterol Hepatol：晚期胰腺癌的术前诱导化疗 Nab-紫杉醇+吉西他滨是否需继以FOLFIRINOX序贯化疗？, objectType=article, longId=204661, objectId=1ee920466151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ee920466151, replyNumber=0, likeNumber=40, createdTime=2020-12-20, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ee920466151, moduleTitle=Lancet Gastroenterol Hepatol：晚期胰腺癌的术前诱导化疗 Nab-紫杉醇+吉西他滨是否需继以FOLFIRINOX序贯化疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ee920466151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555660, encodeId=de931555660bb, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=J Clin Oncol：III期 | 一线诱导化疗后Avelumab维持治疗对晚期胃癌患者预后的作用, objectType=article, longId=203571, objectId=92742035e184, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92742035e184, replyNumber=0, likeNumber=39, createdTime=2020-11-22, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92742035e184, moduleTitle=J Clin Oncol：III期 | 一线诱导化疗后Avelumab维持治疗对晚期胃癌患者预后的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92742035e184)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555659, encodeId=3ed41555659b4, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=ANN ONCOL：诱导化疗后序贯同步放化疗治疗鼻咽癌, objectType=article, longId=150026, objectId=359915002608, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=359915002608, replyNumber=0, likeNumber=33, createdTime=2018-10-01, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=359915002608, moduleTitle=ANN ONCOL：诱导化疗后序贯同步放化疗治疗鼻咽癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=359915002608)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555658, encodeId=e23a15556583c, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=CLIN CANCER RES：诱导化疗+同步放化疗治疗鼻咽癌, objectType=article, longId=136492, objectId=320e13649292, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=320e13649292, replyNumber=0, likeNumber=33, createdTime=2018-04-27, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=320e13649292, moduleTitle=CLIN CANCER RES：诱导化疗+同步放化疗治疗鼻咽癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=320e13649292)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555657, encodeId=fe53155565e0b, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=J CLIN ONCOL：初诊急性髓系白血病伊达比星和大剂量柔红霉素诱导化疗方案比较的前瞻性研究, objectType=article, longId=102864, objectId=785710286461, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=785710286461, replyNumber=0, likeNumber=28, createdTime=2017-06-23, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=785710286461, moduleTitle=J CLIN ONCOL：初诊急性髓系白血病伊达比星和大剂量柔红霉素诱导化疗方案比较的前瞻性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=785710286461)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555656, encodeId=5a59155565624, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=JCO：伊达比星与高剂量柔红霉素通过诱导化疗治疗新诊断急性骨髓性白血病的前瞻性随机比较, objectType=article, longId=102782, objectId=419d102e82a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=419d102e82a7, replyNumber=0, likeNumber=35, createdTime=2017-06-23, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=419d102e82a7, moduleTitle=JCO：伊达比星与高剂量柔红霉素通过诱导化疗治疗新诊断急性骨髓性白血病的前瞻性随机比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=419d102e82a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555655, encodeId=3b6c1555655e9, content=<a href='/topic/show?id=fe2f918e29b' target=_blank style='color:#2F92EE;'>#诱导化疗#</a>, objectTitle=Lancet：诱导化疗治疗IIIA/N2期非小细胞肺癌, objectType=article, longId=54852, objectId=0839548527e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0839548527e, replyNumber=0, likeNumber=34, createdTime=2015-08-15, rootId=0, userName=xinxin088, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0839548527e, moduleTitle=Lancet：诱导化疗治疗IIIA/N2期非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0839548527e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

诱导化疗

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#免疫治疗# #宫颈癌# #辅助治疗# #诱导化疗#

盘点2023｜曹新平教授：2023年宫颈癌领域进展

2024-01-23发表于陕西省

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

Blood Cancer J：小儿急性髓性白血病的两药与三药诱导化疗比较：一项随机对照试验

2022-09-10

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

Lancet Haematol：维奈托克联合诱导化疗治疗新诊断的急性髓性白血病患者

2022-06-05

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

Lancet Haematol：维奈托克联合强化诱导化疗治疗新发急性髓系白血病

2022-05-28

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

JAMA Oncol：紫杉醇+顺铂+卡培他滨诱导化疗可改善晚期鼻咽癌患者的生存预后

2022-04-04

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

Front Oncol：比较同步放化疗联合诱导化疗或辅助化疗在II–IVA期鼻咽癌患者中的疗效和安全性

2021-12-05

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

Front Oncol：诱导化疗联合调强放疗(IMRT)治疗同时性转移鼻咽癌患者的疗效

2021-10-19

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

Front Oncol：局部晚期鼻咽癌三种诱导化疗的疗效和毒性：10年随访结果

2021-10-16

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

Nat Commun：食管鳞状细胞癌中诱导化疗结合根治性放化疗与单独放化疗的疗效比较

2021-07-03

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

J Clin Oncol：Romyelocel-L可显著降低AML患者诱导化疗期间的感染风险

2021-06-26

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

Blood：多发性骨髓瘤老年患者Rd诱导化疗后可单采用低剂量来那度胺维持治疗

2021-06-12

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

Blood：极低风险的ALL患儿采用低强度诱导化疗即可获得很好的预后！

2021-01-17

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

Plos Med：卡非佐米+来那度胺+地塞米松和环磷酰胺用作多发性骨髓瘤移植前诱导化疗的效果和安全性

2021-01-15

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

Lancet Gastroenterol Hepatol：晚期胰腺癌的术前诱导化疗 Nab-紫杉醇+吉西他滨是否需继以FOLFIRINOX序贯化疗？

2020-12-20

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

J Clin Oncol：III期 | 一线诱导化疗后Avelumab维持治疗对晚期胃癌患者预后的作用

2020-11-22

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

ANN ONCOL：诱导化疗后序贯同步放化疗治疗鼻咽癌

2018-10-01

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

CLIN CANCER RES：诱导化疗+同步放化疗治疗鼻咽癌

2018-04-27

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

J CLIN ONCOL：初诊急性髓系白血病伊达比星和大剂量柔红霉素诱导化疗方案比较的前瞻性研究

2017-06-23

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

JCO：伊达比星与高剂量柔红霉素通过诱导化疗治疗新诊断急性骨髓性白血病的前瞻性随机比较

2017-06-23

xinxin088 (审核中...)

前往app查看评论内容

#诱导化疗#

Lancet：诱导化疗治疗IIIA/N2期非小细胞肺癌

2015-08-15

科室
- - 订阅+
  - 更多科室
工具
服务